Product Information
BUSPIRONE HCL 7.5 MG TABLET is a generic product labeled by Apnar Pharma LP, priced at $0.1046 per EA under NDC 24689078501. Its NADAC has been published 207 times since Mar 3, 2021.
FDA first approved this application on May 3, 2018. Its Orange Book therapeutic-equivalence code is BX.
Strength
7.5 mg/1
Manufacturer
Apnar Pharma LPNDC
24689078501
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
BUSPIRONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209696FDA Approved
5/3/2018
TE Code
BX
On Market Since
6/17/2024
Price Statistics
The NADAC for BUSPIRONE HCL 7.5 MG TABLET has been published 207 times since Mar 3, 2021, and over the history we have for it it has declined 61.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1046 per EA |
|---|---|
| All-time high | $0.2986 (May 12, 2021) |
| All-time low | $0.1046 (Aug 19, 2026) |
| 52-week high | $0.1212 |
| 52-week low | $0.1046 |
| Median price | $0.1624 |
| Average price | $0.1749 |
| Largest weekly change | -15.3% (Dec 22, 2021) |
| Weeks tracked | 207 |
| Tracking since | Mar 3, 2021 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUSPIRONE HCL 7.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUSPIRONE HCL 7.5 MG TABLET, manufactured by Apnar Pharma LP, is $0.1046 per EA (NDC 24689078501), effective Aug 19, 2026.
How has the price of BUSPIRONE HCL 7.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUSPIRONE HCL 7.5 MG TABLET has declined 61.5%. It has been tracked across 207 weekly CMS publications since Mar 3, 2021.
What are the highest and lowest recorded NADAC prices for BUSPIRONE HCL 7.5 MG TABLET?
Since Mar 3, 2021, the NADAC for BUSPIRONE HCL 7.5 MG TABLET has ranged from a low of $0.1046 (Aug 19, 2026) to a high of $0.2986 (May 12, 2021), with a median of $0.1624 per EA.
Are there cheaper alternatives to BUSPIRONE HCL 7.5 MG TABLET?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BUSPIRONE HCL 7.5 MG TABLET, is $0.1039 per EA — about 1% below BUSPIRONE HCL 7.5 MG TABLET.
Who manufactures BUSPIRONE HCL 7.5 MG TABLET?
BUSPIRONE HCL 7.5 MG TABLET (NDC 24689078501) is labeled by Apnar Pharma LP, and CMS classifies it as a generic product.